HM17321

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HM17321, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Single Ascending Dose Study of HM17321 in Healthy Adult Participants [Phase 1]